ATE392902T1 - Nigella sativa als medizinische behandlung - Google Patents

Nigella sativa als medizinische behandlung

Info

Publication number
ATE392902T1
ATE392902T1 AT94929736T AT94929736T ATE392902T1 AT E392902 T1 ATE392902 T1 AT E392902T1 AT 94929736 T AT94929736 T AT 94929736T AT 94929736 T AT94929736 T AT 94929736T AT E392902 T1 ATE392902 T1 AT E392902T1
Authority
AT
Austria
Prior art keywords
nigella sativa
medical treatment
sativa
nigella
humans
Prior art date
Application number
AT94929736T
Other languages
English (en)
Inventor
Rajko D Medenica
Original Assignee
Shaker Ghassan I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaker Ghassan I filed Critical Shaker Ghassan I
Application granted granted Critical
Publication of ATE392902T1 publication Critical patent/ATE392902T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94929736T 1993-08-25 1994-08-25 Nigella sativa als medizinische behandlung ATE392902T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/111,631 US5482711A (en) 1993-08-25 1993-08-25 Use of Nigella sativa to increase immune function

Publications (1)

Publication Number Publication Date
ATE392902T1 true ATE392902T1 (de) 2008-05-15

Family

ID=22339582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929736T ATE392902T1 (de) 1993-08-25 1994-08-25 Nigella sativa als medizinische behandlung

Country Status (12)

Country Link
US (2) US5482711A (de)
EP (1) EP0804212B1 (de)
AT (1) ATE392902T1 (de)
AU (1) AU7868794A (de)
BR (1) BR9407362A (de)
CA (1) CA2169956A1 (de)
DE (1) DE69435091D1 (de)
HU (1) HU226319B1 (de)
OA (1) OA10572A (de)
PL (1) PL182890B1 (de)
SI (1) SI9420054B (de)
WO (1) WO1995005839A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1009579A5 (fr) * 1996-07-04 1997-05-06 Ismail Mohamed Tejeddine Systeme vibratoire de protection contre les nuisances des radiations emises par les ecrans de visualisation et/ou autres sources de radiations, d'equilibrage bio-energetique et d'harmonisation geobiologique ou de bio-assainissement des locaux de travail et des habitations.
US6042834A (en) * 1997-01-29 2000-03-28 Baraka; Mohamed Wasif Herbal composition for diabetes and method of treatment
EP0970183B1 (de) * 1997-03-20 2005-10-05 Allen C. Barnes Mikropathologischer abdruck von eines patienten auf basis von vollblut
KR100239879B1 (ko) * 1997-11-05 2000-02-01 김상조 간암 예방 및 치료용 생약제
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US6231866B1 (en) 1998-04-30 2001-05-15 Douglas G. Mann Infused vegetable, fruit, herb, and/or seed fiber product and dietary supplements containing same
US6218434B1 (en) 1998-05-28 2001-04-17 University Of Kentucky Research Foundation Use of the naturally-occurring quinones thymoquinone and dithymoquinone as antineoplastic and cytotoxic agents
DE19844022C1 (de) * 1998-09-25 2000-05-25 Sherif Sabry Ragab Mekkawi Verwendung von eisenbindenden Glycoproteinen und/oder 10-Hydroxy-2-decensäure in Verbindung mit Thymochinon zur Behandlung von AIDS
GB2348132B (en) * 1999-03-02 2004-08-04 Nedaa Abdul-Ghani Nasif Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils
GB9904777D0 (en) 1999-03-02 1999-04-28 Nassief Nida A Novel method, an asthma therapy that act on eosinophils and/or t-lymphocytes
GB2347859B (en) * 1999-03-19 2004-02-25 Yasin Nazir Karim Yakub Herbal compositions
RU2172322C1 (ru) 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды
US6948494B1 (en) * 2000-05-10 2005-09-27 Innovative Devices, Llc. Medicament container with same side airflow inlet and outlet and method of use
AU2003209674A1 (en) * 2002-03-12 2003-09-22 Council Of Scientific And Industrial Research Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
AU2003281259A1 (en) * 2002-07-09 2004-01-23 Shifa Abdo Saeed Ahmed Al Azazi Natural herbal antibiotic for the treatment of the infections of the upper respiratory system and various diseases in the body
US7744929B2 (en) * 2003-09-15 2010-06-29 Ambotan Pharma, Llc Botanical drug compositions for treatments of liver and immunological disorders
US7722906B2 (en) * 2004-03-26 2010-05-25 Biopharm Research & Development Corporation Limited Polyunsaturated fatty acid fractions of Nigella sativa L. seeds
US20050214393A1 (en) * 2004-03-26 2005-09-29 Osama Kandil Lipid fraction of Nigella sativa L. seeds
US20090175970A1 (en) * 2005-01-26 2009-07-09 Veritron Limited Stabilized Plant Extract and Its Therapeutic Use
GB0501654D0 (en) * 2005-01-26 2005-03-02 Veritron Ltd Stabilised plant extract
WO2008021990A2 (en) 2006-08-10 2008-02-21 Barnes Allen C Portable biological testing device and method
FR2922109B1 (fr) 2007-10-16 2010-08-20 Bruno Eto Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre.
CN109776669A (zh) * 2018-12-29 2019-05-21 广州动物园 虎γ干扰素及其表达基因、制备方法和应用
US11260097B2 (en) 2020-07-06 2022-03-01 COVImmune Pharma LLC Immunomodulatory composition to treat and/or prevent COVID-19 illness
US12295982B2 (en) 2021-09-17 2025-05-13 Nasoil, S.A. De C.V. Synergistic composition to treat respiratory diseases and strengthen the immune system to fight other diseases and procedure to manufacture such composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687761A (en) * 1985-05-09 1987-08-18 Yaguang Liu Pharmaceutical composition for increasing immunity and decreasing side effects of anticancer chemotherapy
US4945115A (en) * 1985-05-09 1990-07-31 Yaguang Liu Process for preparing ferulic acid

Also Published As

Publication number Publication date
EP0804212B1 (de) 2008-04-23
AU7868794A (en) 1995-03-21
PL182890B1 (pl) 2002-03-29
HU9600442D0 (en) 1996-04-29
SI9420054B (sl) 2008-10-31
HUT74226A (en) 1996-11-28
SI9420054A (en) 1997-02-28
US5653981A (en) 1997-08-05
CA2169956A1 (en) 1995-02-26
OA10572A (en) 2002-06-03
PL313223A1 (en) 1996-06-10
DE69435091D1 (de) 2008-06-05
EP0804212A2 (de) 1997-11-05
WO1995005839A1 (en) 1995-03-02
US5482711A (en) 1996-01-09
BR9407362A (pt) 1996-04-23
HU226319B1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
DE69435091D1 (de) Nigella sativa als medizinische behandlung
WO1999015167A3 (en) Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer
NZ258019A (en) Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
NZ308789A (en) Tetralin derivatives and medicaments
NO20013727L (no) Anvendelse av Botulinumtoksin B for fremstilling av et medikament
DK0805807T3 (da) 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-(1)-benzopyran til behandling af proliferative sygdomme
DK0725637T3 (da) Parenteralt busulfan til behandling af malign sygdom
FR08C0001I2 (de)
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
AU4830097A (en) Use of an extract of Cimicifuga
DE69322912D1 (de) Kosmetisches und/oder Nahrungsmittel enthaltend eine nicht-verseifbare Fraktion von Sesamöl und Vitamin-E
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
CA2408541A1 (en) Treating eczema and/or psoriasis
ZA943553B (en) Tri(platinum) complexes
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
AU4042795A (en) Treatment of non-small cell lung carcinoma
CA2103708A1 (en) Treatment of ovarian cancer
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
DK0608648T3 (da) Højdoserede vitamin A-præparater
UA30787A (uk) Спосіб лікування хронічного персистуючого гепатиту
GEP20002141B (en) Use of 2-Phenyl-1, 2-Benzisoselenazol-3(2H)-One for Prevention and/or Treatment of Dementia, a Pharmaceutical Composition for Prevention and/or Treatment of the Alzheimer’s Disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties